Literature DB >> 18656548

Virus-sized vaccine delivery systems.

Jean-Pierre Y Scheerlinck1, Deanne L V Greenwood.   

Abstract

In a return to the early days of vaccine development during which effective vaccines were produced against viruses, virus-sized vaccine delivery systems have made a comeback. Using modern production technologies these nanoparticles have proved to be very effective at inducing cellular and humoral immune responses. Here, we review a number of vaccine delivery systems based on nanoparticles in the size range of typical viruses. Different strategies for generating these particles, ranging from recombinant virus-like particles to inert nanobeads via ISCOMs and nanoparticle-based DNA vaccine delivery systems, are discussed. In addition, possible mechanisms of immune induction are explored.

Mesh：

Substances：

Year:  2008        PMID： 18656548     DOI： 10.1016/j.drudis.2008.06.016

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN： 1359-6446            Impact factor:   7.851


  28 in total

Review 1.  Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.

Authors:  Martin F Bachmann; Gary T Jennings
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

2.  A Viral Nanoparticle Cancer Vaccine Delays Tumor Progression and Prolongs Survival in a HER2+ Tumor Mouse Model.

Authors:  Sourabh Shukla; Michal Jandzinski; Chao Wang; Xingjian Gong; Kristen Weber Bonk; Ruth A Keri; Nicole F Steinmetz
Journal:  Adv Ther (Weinh)       Date:  2019-01-29

3.  Multiple Administrations of Viral Nanoparticles Alter in Vivo Behavior-Insights from Intravital Microscopy.

Authors:  Sourabh Shukla; R Dixon Dorand; Jay T Myers; Sarah E Woods; Neetu M Gulati; Phoebe L Stewart; Ulrich Commandeur; Alex Y Huang; Nicole F Steinmetz
Journal:  ACS Biomater Sci Eng       Date:  2016-03-30

4.  Structural-mechanical characterization of nanoparticle exosomes in human saliva, using correlative AFM, FESEM, and force spectroscopy.

Authors:  Shivani Sharma; Haider I Rasool; Viswanathan Palanisamy; Cliff Mathisen; Michael Schmidt; David T Wong; James K Gimzewski
Journal:  ACS Nano       Date:  2010-04-27       Impact factor: 15.881

5.  A novel subnucleocapsid nanoplatform for mucosal vaccination against influenza virus that targets the ectodomain of matrix protein 2.

Authors:  Pierre-Louis Hervé; Mariam Raliou; Christiane Bourdieu; Catherine Dubuquoy; Agnès Petit-Camurdan; Nicolas Bertho; Jean-François Eléouët; Christophe Chevalier; Sabine Riffault
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

6.  Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts.

Authors:  Anderson Paul Kanagaraj; Dheeraj Verma; Henry Daniell
Journal:  Plant Mol Biol       Date:  2011-03-24       Impact factor: 4.076

Review 7.  Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses.

Authors:  Moses O Oyewumi; Amit Kumar; Zhengrong Cui
Journal:  Expert Rev Vaccines       Date:  2010-09       Impact factor: 5.217

Review 8.  Emerging nanotechnologies for cancer immunotherapy.

Authors:  Sourabh Shukla; Nicole F Steinmetz
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-04

Review 9.  Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists.

Authors:  Matthew Black; Amanda Trent; Matthew Tirrell; Colleen Olive
Journal:  Expert Rev Vaccines       Date:  2010-02       Impact factor: 5.217

Review 10.  Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID).

Authors:  Amir Seyfoori; Mahdieh Shokrollahi Barough; Pooneh Mokarram; Mazaher Ahmadi; Parvaneh Mehrbod; Alireza Sheidary; Tayyebeh Madrakian; Mohammad Kiumarsi; Tavia Walsh; Kielan D McAlinden; Chandra C Ghosh; Pawan Sharma; Amir A Zeki; Saeid Ghavami; Mohsen Akbari
Journal:  Int J Mol Sci       Date:  2021-06-28       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.